Alder BioPharmaceuticals® Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

World News: . []

BOTHELL Wash Sept 14 2018 GLOBE NEWSWIRE -- Alder BioPharmaceuticals Inc (Nasdaq: ALDR a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine today reported that the Compensation Co mmittee...

More news and information about Alder Biopharmaceuticals, Inc.

Published By:

Globe Newswire: 22:00 GMT Friday 14th September 2018

Published: .

Search for other references to "alder" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.
 
Privacy Policy | Terms and Conditions | Contact Us